The U.S. Food and Drug Administration (FDA) said Pfizer’s Covid-19 vaccine is safe and effective for children under five, ahead of its meeting later this week to review its authorization in the United States.
At a time when hospitalization and death rates are “highest among children and adolescents aged 5 to 17,” the FDA is the only age group not yet eligible for vaccination in the United States and most countries. A document released on Sunday.
The agency held an expert meeting on June 15 to decide whether to recommend three doses of three micrograms of Pfizer vaccine to children aged six months to four years; and two doses of Moderna vaccine for children aged six months to five years.
source: Noticias
[author_name]